BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized double-blind (investigator and subject blinded), placebo controlled
ascending single dose study to evaluate the safety, tolerability, and pharmacokinetic profile
of BPN14770 in healthy male and female subjects. Each subject will be randomized to receive
either a single dose of BPN14770 or placebo.